<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Meijer, D.N.</title>
    <link>http://repub.eur.nl/res/aut/433/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>A hypomorphic mutation in Lpin1 induces progressively improving neuropathy and lipodystrophy in the rat (Article)</title>
      <link>http://repub.eur.nl/res/pub/31373/</link>
      <pubDate>2011-07-29T00:00:00Z</pubDate>
      <description>The Lpin1 gene encodes the phosphatidate phosphatase (PAP1) enzyme Lipin 1, which plays a critical role in lipid metabolism. In this study we describe the identification and characterization of a rat model with a mutated Lpin1 gene (Lpin11Hubr), generated by N-ethyl-N-nitrosourea mutagenesis. Lpin11Hubrrats are characterized by hindlimb paralysis and mild lipodystrophy that are detectable from the second postnatal week. Sequencing of Lpin1 identified a point mutation in the 5′-end splice site of intron 18 resulting in missplicing, a reading frameshift, and a premature stop codon. As this mutation does not induce nonsense-mediated decay, it allows the production of a truncated Lipin 1 protein lacking PAP1 activity. Lpin11Hubrrats developed hypomyelination and mild lipodystrophy rather than the pronounced demyelination and adipocyte defects characteristic of Lpin1fld/fldmice, which carry a null allele for Lpin1. Furthermore, biochemical, histological, and molecular analyses revealed that these lesions improve in older Lpin11Hubrrats as compared with young Lpin11Hubrrats and Lpin1fld/fldmice. We observed activation of compensatory biochemical pathways substituting for missing PAP1 activity that, in combination with a possible non-enzymatic Lipin 1 function residing outside of its PAP1 domain, may contribute to the less severe phenotypes observed in Lpin11Hubrrats as compared with Lpin1fld/fldmice. Although we are cautious in making a direct parallel between the presented rodent model and human disease, our data may provide new insight into the pathogenicity of recently identified human LPIN1 mutations. </description>
    </item> <item>
      <title>Functional dissection of the Oct6 schwann cell enhancer reveals an essential role for dimeric sox10 binding (Article)</title>
      <link>http://repub.eur.nl/res/pub/33766/</link>
      <pubDate>2011-06-08T00:00:00Z</pubDate>
      <description>The POU domain transcription factor Pou3f1 (Oct6/Scip/Tst1) initiates the transition from ensheathing, promyelinating Schwann cells to myelinating cells. Axonal and other extracellular signals regulate Oct6 expression through the Oct6 Schwann cell enhancer (SCE), which is both required and sufficient to drive all aspects of Oct6 expression in Schwann cells. Thus, the Oct6 SCE is pivotal in the gene regulatory network that governs the onset of myelin formation in Schwann cells and provides a link between myelin promoting signaling and activation of a myelin-related transcriptional network. In this study, we define the relevant cis-acting elements within the SCE and identify the transcription factors that mediate Oct6 regulation. On the basis of phylogenetic comparisons and functional in vivo assays, we identify a number of highly conserved core elements within the mouse SCE. We show that core element 1 is absolutely required for full enhancer function and that it contains closely spaced inverted binding sites for Sox proteins. For the first time in vivo, the dimeric Sox10 binding to this element is shown to be essential for enhancer activity, whereas monomeric Sox10 binding is nonfunctional. As Oct6 and Sox10 synergize to activate the expression of the major myelin-related transcription factor Krox20, we propose that Sox10-dependent activation of Oct6 defines a feedforward regulatory module that serves to time and amplify the onset of myelination in the peripheral nervous system. </description>
    </item> <item>
      <title>HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/25554/</link>
      <pubDate>2011-04-01T00:00:00Z</pubDate>
      <description>Histone deacetylases (HDACs) are major epigenetic regulators. We show that HDAC1 and HDAC2 functions are critical for myelination of the peripheral nervous system. Using mouse genetics, we have ablated Hdac1 and Hdac2 specifically in Schwann cells, resulting in massive Schwann cell loss and virtual absence of myelin in mutant sciatic nerves. Expression of Sox10 and Krox20, the main transcriptional regulators of Schwann cell myelination, was greatly reduced. We demonstrate that in Schwann cells, HDAC1 and HDAC2 exert specific primary functions: HDAC2 activates the transcriptional program of myelination in synergy with Sox10, whereas HDAC1 controls Schwann cell survival by regulating the levels of active Î 2-catenin. </description>
    </item> <item>
      <title>Assessing the role of the cadherin/catenin complex at the Schwann cell-axon interface and in the initiation of myelination (Article)</title>
      <link>http://repub.eur.nl/res/pub/23884/</link>
      <pubDate>2011-02-23T00:00:00Z</pubDate>
      <description>Myelination is dependent on complex reciprocal interactions between the Schwann cell (SC) and axon. Recent evidence suggests that the SC-axon interface represents a membrane specialization essential for myelination; however, the manner in which this polarized-apical domain is generated remains a mystery. The cell adhesion molecule N-cadherin is enriched at the SC-axon interface and colocalizes with the polarity protein Par-3. The asymmetric localization is induced on SC-SC and SC-axon contact. Knockdown of N-cadherin in SCs cocultured with DRG neurons disrupts Par-3 localization and delays the initiation of myelination. However, knockdown or overexpression of neuronal N-cadherin does not influence the distribution of Par-3 or myelination, suggesting that homotypic interactions between SC and axonal N-cadherin are not essential for the events surrounding myelination. To further investigate the role of N-cadherin, mice displaying SC-specific gene ablation of N-cadherin were generated and characterized. Surprisingly, myelination is only slightly delayed, and mice are viable without any detectable myelination defects. β-Catenin, a downstream effector of N-cadherin, colocalizes and coimmunoprecipitates with N-cadherin on the initiation of myelination. To determine whether β-catenin mediates compensation on N-cadherin deletion, SC-specific gene ablation of β-catenin was generated and characterized. Consistent with our hypothesis, myelination is more severely delayed than when manipulating N-cadherin alone, but without any defect to the myelin sheath. Together, our results suggest that N-cadherin interacts with β-catenin in establishing SC polarity and the timely initiation of myelination, but they are nonessential components for the formation and maturation of the myelin sheath. Copyright </description>
    </item> <item>
      <title>Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage (Article)</title>
      <link>http://repub.eur.nl/res/pub/27653/</link>
      <pubDate>2010-05-17T00:00:00Z</pubDate>
      <description>Mutations in the transcription factor SOX10 cause neurocristopathies, including Waardenburg-Hirschsprung syndrome and peripheral neuropathies in humans. This is partly attributed to a requirement for Sox10 in early neural crest for survival, maintenance of pluripotency, and specification to several cell lineages, including peripheral glia. As a consequence, peripheral glia are absent in Sox10-deficient mice. Intriguingly, Sox10 continues to be expressed in these cells after specification. To analyze glial functions after specification, we specifically deleted Sox10 in immature Schwann cells by conditional mutagenesis. Mutant mice died from peripheral neuropathy before the seventh postnatal week. Nerve alterations included a thinned perineurial sheath, increased lipid and collagen deposition, and a dramatically altered cellular composition. Nerve conduction was also grossly aberrant, and neither myelinating nor non-myelinating Schwann cells formed. Instead, axons of different sizes remained unsorted in large bundles. Schwann cells failed to develop beyond the immature stage and were unable to maintain identity. Thus, our study identifies a novel cause for peripheral neuropathies in patients with SOX10 mutations. </description>
    </item> <item>
      <title>Dicer in Schwann cells is required for myelination and axonal integrity (Article)</title>
      <link>http://repub.eur.nl/res/pub/27853/</link>
      <pubDate>2010-05-12T00:00:00Z</pubDate>
      <description>Dicer is responsible for the generation of mature micro-RNAs (miRNAs) and loading them into RNA-induced silencing complex (RISC). RISC functions as a probe that targets mRNAs leading to translational suppression and mRNA degradation. Schwann cells (SCs) in the peripheral nervous system undergo remarkable differentiation both in morphology and gene expression patterns throughout lineage progression to myelinating and nonmyelinating phenotypes. Gene expression in SCs is particularly tightly regulated and critical for the organism, as highlighted by the fact that a 50% decrease or an increase to 150% of normal gene expression of some myelin proteins, like PMP22, results in peripheral neuropathies. Here, we selectively deleted Dicer and consequently gene expression regulation by mature miRNAs from Mus musculus SCs. Our results show that in the absence of Dicer, most SCs arrest at the promyelinating stage and fail to start forming myelin. At the molecular level, the promyelinating transcription factor Krox20 and several myelin proteins [including myelin associated glycoprotein (MAG) and PMP22] were strongly reduced in mutant sciatic nerves. In contrast, the myelination inhibitors SOX2, Notch1, and Hes1 were increased, providing an additional potential basis for impaired myelination. A minor fraction of SCs, with some peculiar differences between sensory and motor fibers, overcame the myelination block and formed unusually thin myelin, in line with observed impaired neuregulin and AKT signaling. Surprisingly, we also found signs of axonal degeneration in Dicer mutant mice. Thus, our data indicate that miRNAs critically regulate Schwann cell gene expression that is required for myelination and to maintain axons via axon- glia interactions. Copyright </description>
    </item> <item>
      <title>Adam22 is a major neuronal receptor for Lgi4-mediated Schwann cell signaling (Article)</title>
      <link>http://repub.eur.nl/res/pub/27854/</link>
      <pubDate>2010-03-10T00:00:00Z</pubDate>
      <description>The segregation and myelination of axons in the developing PNS, results from a complex series of cellular and molecular interactions between Schwann cells and axons. Previously we identified the Lgi4 gene (leucine-rich glioma-inactivated4) as an important regulator of myelination in the PNS, and its dysfunction results in arthrogryposis as observed in claw paw mice. Lgi4 is a secreted protein and a member of a small family of proteins that are predominantly expressed in the nervous system. Their mechanism of action is unknown but may involve binding to members of the Adam (A disintegrin and metalloprotease) family of transmembrane proteins, in particular Adam22. We found that Lgi4 and Adam22 are both expressed in Schwann cells as well as in sensory neurons and that Lgi4 binds directly to Adam22 without a requirement for additional membrane associated factors. To determine whether Lgi4-Adam22 function involves a paracrine and/or an autocrine mechanism of action we performed heterotypic Schwann cell sensory neuron cultures and cell typespecific ablation of Lgi4 and Adam22 in mice. We show that Schwann cells are the principal cellular source of Lgi4 in the developing nerve and that Adam22 is required on axons. Our results thus reveal a novel paracrine signaling axis in peripheral nerve myelination in which Schwann cell secreted Lgi4 functions through binding of axonal Adam22 to drive the differentiation of Schwann cells. Copyright </description>
    </item> <item>
      <title>ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons (Article)</title>
      <link>http://repub.eur.nl/res/pub/27868/</link>
      <pubDate>2010-01-20T00:00:00Z</pubDate>
      <description>Clustered Kv1 K+channels regulate neuronal excitability at juxtaparanodes of myelinated axons, axon initial segments, and cerebellar basket cell terminals (BCTs). These channels are part of a larger protein complex that includes cell adhesion molecules and scaffolding proteins. To identify proteins that regulate assembly, clustering, and/or maintenance of axonal Kv1 channel protein complexes, we immunoprecipitated Kv1.2 αsubunits, and then used mass spectrometry to identify interacting proteins.We found that a disintegrin and metalloproteinase 22 (ADAM22) is a component of the Kv1 channel complex and that ADAM22 coimmunoprecipitates Kv1.2 and the membrane-associated guanylate kinases (MAGUKs) PSD-93 and PSD-95. When coexpressed with MAGUKs in heterologous cells, ADAM22 and Kv1 channels are recruited into membrane surface clusters. However, coexpression of Kv1.2 with ADAM22 and MAGUKs does not alter channel properties. Among all the known Kv1 channel-interacting proteins, only ADAM22 is found at every site where Kv1 channels are clustered. Analysis of Caspr-null mice showed that, like other previously described juxtaparanodal proteins, disruption of the paranodal junction resulted in redistribution of ADAM22 into paranodal zones. Analysis of Caspr2-, PSD-93-, PSD-95-, and double PSD-93/PSD-95-null mice showed ADAM22 clustering at BCTs requires PSD-95, but ADAM22 clustering at juxtaparanodes requires neither PSD-93 nor PSD-95. In direct contrast, analysis of ADAM22-null mice demonstrated juxtaparanodal clustering of PSD-93 and PSD-95 requires ADAM22, whereas Kv1.2 and Caspr2 clustering is normal in ADAM22-null mice. Thus, ADAM22 is an axonal component of the Kv1 K+channel complex that recruits MAGUKs to juxtaparanodes. Copyright </description>
    </item> <item>
      <title>Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity (Article)</title>
      <link>http://repub.eur.nl/res/pub/24586/</link>
      <pubDate>2009-07-01T00:00:00Z</pubDate>
      <description>Notch signaling is central to vertebrate development, and analysis of Notch has provided important insights into pathogenetic mechanisms in the CNS and many other tissues. However, surprisingly little is known about the role of Notch in the development and pathology of Schwann cells and peripheral nerves. Using transgenic mice and cell cultures, we found that Notch has complex and extensive regulatory functions in Schwann cells. Notch promoted the generation of Schwann cells from Schwann cell precursors and regulated the size of the Schwann cell pool by controlling proliferation. Notch inhibited myelination, establishing that myelination is subject to negative transcriptional regulation that opposes forward drives such as Krox20. Notably, in the adult, Notch dysregulation resulted in demyelination; this finding identifies a signaling pathway that induces myelin breakdown in vivo. These findings are relevant for understanding the molecular mechanisms that control Schwann cell plasticity and underlie nerve pathology, including demyelinating neuropathies and tumorigenesis. </description>
    </item> <item>
      <title>Plexiform and Dermal Neurofibromas and Pigmentation Are Caused by Nf1 Loss in Desert Hedgehog-Expressing Cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/30400/</link>
      <pubDate>2008-02-05T00:00:00Z</pubDate>
      <description>Neurofibromatosis type 1 (Nf1) mutation predisposes to benign peripheral nerve (glial) tumors called neurofibromas. The point(s) in development when Nf1 loss promotes neurofibroma formation are unknown. We show that inactivation of Nf1 in the glial lineage in vitro at embryonic day 12.5 + 1, but not earlier (neural crest) or later (mature Schwann cell), results in colony-forming cells capable of multilineage differentiation. In vivo, inactivation of Nf1 using a DhhCre driver beginning at E12.5 elicits plexiform neurofibromas, dermal neurofibromas, and pigmentation. Tumor Schwann cells uniquely show biallelic Nf1 inactivation. Peripheral nerve and tumors contain transiently proliferating Schwann cells that lose axonal contact, providing insight into early neurofibroma formation. We suggest that timing of Nf1 mutation is critical for neurofibroma formation. </description>
    </item> <item>
      <title>Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development (Article)</title>
      <link>http://repub.eur.nl/res/pub/35364/</link>
      <pubDate>2007-06-18T00:00:00Z</pubDate>
      <description>During peripheral nervous system (PNS) myelination, Schwann cells must interpret extracellular cues to sense their environment and regulate their intrinsic developmental program accordingly. The pathways and mechanisms involved in this process are only partially understood. We use tissue-specific conditional gene targeting to show that members of the Rho GTPases, cdc42 and rac1, have different and essential roles in axon sorting by Schwann cells. Our results indicate that although cdc42 is required for normal Schwann cell proliferation, rac1 regulates Schwann cell process extension and stabilization, allowing efficient radial sorting of axon bundles. </description>
    </item> <item>
      <title>The protooncogene ski controls schwann cell proliferation and myelination (Article)</title>
      <link>http://repub.eur.nl/res/pub/31813/</link>
      <pubDate>2004-08-19T00:00:00Z</pubDate>
      <description>Schwann cell proliferation and subsequent differentiation to nonmyelinating and myelinating cells are closely linked processes. Elucidating the molecular mechanisms that control these events is key to the understanding of nerve development, regeneration, nerve-sheath tumors, and neuropathies. We define the protooncogene Ski, an inhibitor of TGF-β signaling, as an essential component of the machinery that controls Schwann cell proliferation and myelination. Functional Ski overexpression inhibits TGF-β-mediated proliferation and prevents growth-arrested Schwann cells from reentering the cell cycle. Consistent with these findings, myelinating Schwann cells upregulate Ski during development and remyelination after injury. Myelination is blocked in myelin-competent cultures derived from Ski-deficient animals, and genes encoding myelin components are downregulated in Ski-deficient nerves. Conversely, overexpression of Ski in Schwann cells causes an upregulation of myelin-related genes. The myelination-regulating transcription factor Oct6 is involved in a complex modulatory relationship with Ski. We conclude that Ski is a crucial signal in Schwann cell development and myelination.</description>
    </item> <item>
      <title>Cell autonomy of the mouse claw paw mutation. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2659/</link>
      <pubDate>2004-08-15T00:00:00Z</pubDate>
      <description>Mice homozygous for the autosomal recessive mutation claw paw (clp) are characterized by limb posture abnormalities and congenital hypomyelination, with delayed onset of myelination of the peripheral nervous system but not the central nervous system. Although this combination of limb and peripheral nerve abnormalities in clp/clp mice might suggest a common neurogenic origin of the syndrome, it is not clear whether the clp gene acts primarily in the neurone, the Schwann cell or both. In the work described here, we address this question of cell autonomy of the clp mutation through reciprocal nerve grafting experiments between wild-type and clp/clp animals. Our results demonstrate that the clp mutation affects the Schwann cell compartment and possibly also the neuronal compartment. These data suggest that the clp gene product is expressed in Schwann cells as well as neurones and is likely to be involved in direct axon--Schwann cell interactions. Within the Schwann cell, clp affects a myelin-related signaling pathway that regulates periaxin and Krox-20 expression, but not Oct-6.</description>
    </item> <item>
      <title>HS5 of the human β-globin Locus Control Region: a developmental stage-specific border in erythroid cells. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2643/</link>
      <pubDate>2003-09-01T00:00:00Z</pubDate>
      <description>Elements with insulator/border activity have been characterized most extensively in Drosophila melanogaster. In vertebrates, the first example of such an element was provided by a hypersensitive site of the chicken beta-globin locus, cHS4. It has been proposed that the homologous site in humans, HS5, functions as a border of the human beta-globin locus. Here, we have characterized HS5 of the human beta-globin locus control region. We have examined its tissue-specificity and assessed its insulating properties in transgenic mice using a lacZ reporter assay. Most importantly, we have tested its enhancer blocking activity in the context of the full beta-globin locus. Our results show that HS5 is erythroid-specific rather than ubiquitous in human tissues. Furthermore, HS5 does not fulfil the criteria of a general in vivo insulator in the transgene protection assay. Finally, a HS5 conditional deletion from the complete locus demonstrates that HS5 has no discernable activity in adult erythroid cells. Surprisingly, HS5 functions as an enhancer blocker in embryonic erythroid cells. We conclude that HS5 is a developmental stage-specific border in erythroid cells.</description>
    </item> <item>
      <title>A tissue-specific knockout reveals that Gata1 is not essential for Sertoli cell function in the mouse (Article)</title>
      <link>http://repub.eur.nl/res/pub/10216/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>The transcription factor Gata1 is essential for the development of
      erythroid cells. Consequently, Gata1 null mutants die in utero due to
      severe anaemia. Outside the haematopoietic system, Gata1 is only expressed
      in the Sertoli cells of the testis. To elucidate the function of Gata1 in
      the testis, we made a Sertoli cell-specific knockout of the Gata1 gene in
      the mouse. We deleted a normally functioning 'floxed' Gata1 gene in
      pre-Sertoli cells in vivo through the expression of Cre from a transgene
      driven by the Desert Hedgehog promoter. Surprisingly, Gata1 null testes
      developed to be morphologically normal, spermatogenesis was not obviously
      affected and expression levels of putative Gata1 target genes, and other
      Gata factors, were not altered. We conclude that expression of Gata1 in
      Sertoli cells is not essential for testis development or spermatogenesis
      in the mouse.</description>
    </item> <item>
      <title>A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve 	development and regeneration. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2635/</link>
      <pubDate>2002-09-02T00:00:00Z</pubDate>
      <description>While an important role for the POU domain transcription factor Oct-6 in the developing peripheral nerve has been well established, studies into its exact role in nerve development and regeneration have been hampered by the high mortality rate of newborn Oct-6 mutant animals. In this study we have generated a Schwann cell-specific Oct-6 allele through deletion of the Schwann cell-specific enhancer element (SCE) in the Oct-6 locus. Analysis of mice homozygous for this allele (ΔSCE allele) reveals that rate-limiting levels of Oct-6 in Schwann cells are dependent on the SCE and that this element does not contribute to Oct-6 regulation in other cell types. We demonstrate a Schwann cell autonomous function for Oct-6 during nerve development as well as in regenerating nerve. Additionally, we show that Krox-20, an important regulatory target of Oct-6 in Schwann cells, is activated, with delayed kinetics, through an Oct-6-independent mechanism in these mice.</description>
    </item> <item>
      <title>A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration (Article)</title>
      <link>http://repub.eur.nl/res/pub/9965/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>While an important role for the POU domain transcription factor Oct-6 in
      the developing peripheral nerve has been well established, studies into
      its exact role in nerve development and regeneration have been hampered by
      the high mortality rate of newborn Oct-6 mutant animals. In this study we
      have generated a Schwann cell-specific Oct-6 allele through deletion of
      the Schwann cell-specific enhancer element (SCE) in the Oct-6 locus.
      Analysis of mice homozygous for this allele (deltaSCE allele) reveals that
      rate-limiting levels of Oct-6 in Schwann cells are dependent on the SCE
      and that this element does not contribute to Oct-6 regulation in other
      cell types. We demonstrate a Schwann cell autonomous function for Oct-6
      during nerve development as well as in regenerating nerve. Additionally,
      we show that Krox-20, an important regulatory target of Oct-6 in Schwann
      cells, is activated, with delayed kinetics, through an Oct-6-independent
      mechanism in these mice.</description>
    </item> <item>
      <title>Comparison of sequence and function of the Oct-6 genes in zebrafish, chicken and mouse. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2562/</link>
      <pubDate>1998-06-01T00:00:00Z</pubDate>
      <description>To examine the role of the Oct-6 gene in Schwann cell differentiation we have cloned and characterized the chicken and zebrafish homologues of the mouse Oct-6 gene. While highly homologous in the Pit1-Oct1/2-Unc86 (POU) domain, sequence similarities are limited outside this domain. Both genes are intronless and both proteins lack the amino acid repeats that are a characteristic feature of the mammalian Oct-6 proteins. However as in mammals, the aminoterminal parts of the chicken and zebrafish Oct-6 proteins are essential for transactivation of octamer containing promoters. By immunohistochemistry we have found that the chicken Oct-6 protein is expressed in late embryonic ensheathing Schwann cells of the sciatic nerve and is rapidly downregulated when myelination proceeds. This expression profile in glial cells is identical to that in the mouse and rat. Furthermore the zebrafish Oct-6 homolog is expressed in the posterior lateral nerve at a time when it contains actively myelinating Schwann cells. Thus despite extensive primary sequence divergence among the vertebrate Oct-6 proteins, the expression of the chicken and zebrafish Oct-6 proteins is consistent with the notion that Oct-6 functions as a 'competence factor' in promyelin cells to execute the myelination program.</description>
    </item> <item>
      <title>The POU factor Oct-6 is required for the progression of Schwann cell differentiation in peripheral nerves. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2529/</link>
      <pubDate>1996-01-01T00:00:00Z</pubDate>
      <description>The POU transcription factor Oct-6, also known as SCIP or Tst-1, has been implicated as a major transcriptional regulator in Schwann cell differentiation. Microscopic and immunochemical analysis of sciatic nerves of Oct-6(-/-) mice at different stages of postnatal development reveals a delay in Schwann cell differentiation, with a transient arrest at the promyelination stage. Thus, Oct-6 appears to be required for the transition of promyelin cells to myelinating cells. Once these cells progress past this point, Oct-6 is no longer required, and myelination occurs normally.</description>
    </item> <item>
      <title>The rat androgen receptor gene promoter (Article)</title>
      <link>http://repub.eur.nl/res/pub/8890/</link>
      <pubDate>1990-01-01T00:00:00Z</pubDate>
      <description>The androgen receptor (AR) is activated upon binding of testosterone or
      dihydrotestosterone and exerts regulatory effects on gene expression in
      androgen target cells. To study transcriptional regulation of the rat AR
      gene itself, the 5' genomic region of this gene was cloned from a genomic
      library and the promoter was identified. S1-nuclease protection analysis
      showed two major transcription start sites, located between 1010 and 1023
      bp upstream from the translation initiation codon. The area surrounding
      these start sites was cloned in both orientations in a CAT reporter
      plasmid. Upon transfection of the constructs into COS cells, part of the
      promoter stimulated transcription in an orientation-independent manner,
      but the full promoter showed a higher and unidirectional activity. In the
      promoter/reporter gene constructs, transcription initiated from the same
      positions as in the native gene. Sequence analysis showed that the
      promoter of the rat AR gene lacks typical TATA and CCAAT box elements, but
      one SP1 site is located at about 60 bp upstream from the major start site
      of transcription. Other possible promoter elements are TGTYCT sequences at
      positions -174 to -179, -434 to -439., -466 to -471, and -500 to -505,
      resembling half-sites of the glucocorticoid-responsive element (GRE).
      Furthermore, a homopurine stretch containing a total of 8 GGGGA elements
      and similar to sequences that are present in several other GC-rich
      promoters, is located between -89 and -146 bp upstream from the major
      start site of transcription</description>
    </item> <item>
      <title>Evolution and mutagenesis of the mammalian excision repair gene ERCC-1 (Article)</title>
      <link>http://repub.eur.nl/res/pub/3002/</link>
      <pubDate>1988-01-01T00:00:00Z</pubDate>
      <description>The human DNA excision repair protein ERCC-1 exhibits homology to the yeast RADIO repair protein and its longer C-terminus displays similarity to parts of the E.coli repair proteins uvrA and uvrC. To study the evolution of this 'mosaic' ERCC-1 gene we have isolated the mouse homologue. Mouse ERCC-1 harbors the same pattern of homology with RAD10 and has a comparable C-terminal extension as its human equivalent. Mutation studies show that the strongly conserved C-terminus is essential in contrast to the less conserved N-terminus which is even dispensible. The mouse ERCC-1 amino acid sequence is compatible with a previously postulated nuclear location signal and DNA-binding domain. The ERCC-1 promoter harbors a region which is highly conserved in mouse and man. Since the ERCC-1 promoter is devoid of all classical promoter elements this region may be responsible for the low constitutive level of expression in all mouse tissues and stages of embryogenesis examined.</description>
    </item> <item>
      <title>The structure of a human neurofilament gene (NF-L): A unique exon-intron organization in the intermediate filament gene family. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2408/</link>
      <pubDate>1987-01-01T00:00:00Z</pubDate>
      <description>We have cloned and determined the nucleotide sequence of the human gene for the neurofilament subunit NF-L. The cloned DNA contains the entire transcriptional unit and generates two mRNAs of approx. 2.6 and 4.3 kb after transfection into mouse L-cells. The NF-L gene has an unexpected intron-exon organization in that it entirely lacks introns at positions found in other members of the intermediate filament gene family. It contains only three introns that do not define protein domains. We discuss possible evolutionary schemes that could explain these results.</description>
    </item> <item>
      <title>The human neurofilament gene (NEFL) is located on the short arm of chromosome 8. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2414/</link>
      <pubDate>1987-01-01T00:00:00Z</pubDate>
      <description>We have localized the gene coding for the human neurofilament light chain (NEFL) to chromosome band 8p2.1 by Southern blotting of DNA from hybrid cell panels and in situ hybridization to metaphase chromosomes.</description>
    </item> <item>
      <title>Cloning and developmental expression of the murine neurofilament gene family. (Article)</title>
      <link>http://repub.eur.nl/res/pub/2397/</link>
      <pubDate>1986-01-01T00:00:00Z</pubDate>
      <description>DNA clones encoding the 3 mouse neurofilament (NF) genes have been isolated by cross-hybridization with a previously described NF-L cDNA probe from the rat. Screening of a lambda gt10 cDNA library prepared from mouse brain RNA led to the cloning of an NF-L cDNA of 2.0 kb that spans the entire coding region of 541 amino acids and of an NF-M cDNA that covers 219 amino acids from the internal alpha-helical region and the carboxy-terminal domains of the protein. These cDNA clones were used as probes to screen mouse genomic libraries, and cosmid clones containing both NF-L and NF-M sequences were isolated as well as overlapping cosmids containing the NF-H gene. This strongly suggests that the 3 neurofilament genes are organised in a cluster and derived by gene duplication of a common ancestral gene. RNA blot analyses using specific DNA probes for each of the genes indicate that NF mRNAs are differentially expressed during brain development. The NF-L and NF-M mRNAs are detected early in the embryonal brain, with a progressive increase in their levels during development, while the NF-H mRNA is barely detectable at embryonal stages and accumulates later in the postnatal brain.</description>
    </item>
  </channel>
</rss>